{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:04:29Z","timestamp":1787504669290,"version":"build-2736575974"},"reference-count":16,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.vaccine.2021.04.060","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T08:20:41Z","timestamp":1620807641000},"page":"3633-3640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Immunogenicity and safety of two monovalent rotavirus vaccines, ROTAVAC\u00ae and ROTAVAC 5D\u00ae in Zambian infants"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0221-9527","authenticated-orcid":false,"given":"R.","family":"Chilengi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Mwila- Kazimbaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Chirwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sukwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2908-1575","authenticated-orcid":false,"given":"C.","family":"Chipeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Velu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Katanekwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Babji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"McNeal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6371-1772","authenticated-orcid":false,"given":"N.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gompana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hazra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9249-5028","authenticated-orcid":false,"given":"N.","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5560-5504","authenticated-orcid":false,"given":"N.","family":"Rathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2021.04.060_b0005","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/cid\/civ1013","article-title":"Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000\u20132013","volume":"62","author":"Tate","year":"2016","journal-title":"Clinical Infectious Diseases"},{"issue":"10","key":"10.1016\/j.vaccine.2021.04.060_b0010","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1001\/jamapediatrics.2018.1960","article-title":"Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years","volume":"172","author":"Troeger","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"3","key":"10.1016\/j.vaccine.2021.04.060_b0015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1086\/600104","article-title":"A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial","volume":"200","author":"Bhandari","year":"2009","journal-title":"Journal of Infectious Diseases"},{"issue":"9935","key":"10.1016\/j.vaccine.2021.04.060_b0020","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/S0140-6736(13)62630-6","article-title":"Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial","volume":"383","author":"Bhandari","year":"2014","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2021.04.060_b0025","doi-asserted-by":"crossref","first-page":"A110","DOI":"10.1016\/j.vaccine.2014.04.079","article-title":"Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life","volume":"32","author":"Bhandari","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.060_b0030","first-page":"1","article-title":"A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC(R), administered simultaneously with or without the buffering agent in healthy infants in India","author":"Ella","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"10.1016\/j.vaccine.2021.04.060_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2017.e00302","article-title":"ROTAVAC((R)) does not interfere with the immune response to childhood vaccines in Indian infants: A randomized placebo controlled trial","volume":"3","author":"Chandola","year":"2017","journal-title":"Heliyon"},{"issue":"31","key":"10.1016\/j.vaccine.2021.04.060_b0040","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1016\/j.vaccine.2019.05.069","article-title":"A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC(R) in comparison with a licensed rotavirus vaccine in healthy infants","volume":"37","author":"Ella","year":"2019","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2021.04.060_b0045","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1093\/cid\/civ1027","article-title":"Impact of Rotavirus Vaccination on Diarrheal Hospitalizations in Children Aged <5 Years in Lusaka","volume":"62","author":"Mpabalwani","year":"2016","journal-title":"Zambia. Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2021.04.060_b0050","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-2603","article-title":"Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules","volume":"137","author":"Libster","year":"2016","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.vaccine.2021.04.060_b0055","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0264-410X(97)00210-7","article-title":"Safety and immunogenicity of live, attenuated human rotavirus vaccine 89\u201312","volume":"16","author":"Bernstein","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.04.060_b0060","unstructured":"Organization, W.H., Manual of rotavirus detection and characterization methods. Geneva: World Health Organization; 2009. WHO\/IVB\/08.17. 2009: p. viii, 146 p."},{"issue":"12","key":"10.1016\/j.vaccine.2021.04.060_b0065","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1086\/421248","article-title":"Rotavirus immunoglobulin a responses stimulated by each of 3 doses of a quadrivalent human\/bovine reassortant rotavirus vaccine","volume":"189","author":"Ward","year":"2004","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1016\/j.vaccine.2021.04.060_b0070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/sim.4780040211","article-title":"Comparative analysis of two rates","volume":"4","author":"Miettinen","year":"1985","journal-title":"Statistics in Medicine"},{"issue":"19","key":"10.1016\/j.vaccine.2021.04.060_b0075","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.vaccine.2019.03.067","article-title":"Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL - Liquid) in Indian infants","volume":"37","author":"Kawade","year":"2019","journal-title":"Vaccine"},{"issue":"25","key":"10.1016\/j.vaccine.2021.04.060_b0080","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1016\/j.vaccine.2014.03.013","article-title":"Human and bovine rotavirus strain antigens for evaluation of immunogenicity in a randomized, double-blind, placebo-controlled trial of a single dose live attenuated tetravalent, bovine-human-reassortant, oral rotavirus vaccine in Indian adults","volume":"32","author":"Paul","year":"2014","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21005429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21005429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:57:16Z","timestamp":1759402636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21005429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":16,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0264410X21005429"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.04.060","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of two monovalent rotavirus vaccines, ROTAVAC\u00ae and ROTAVAC 5D\u00ae in Zambian infants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.04.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}